Cite
HARVARD Citation
Elumalai, T. et al. (2022). Early Real-world Safety Data of Darolutamide in Non-metastatic Castrate-resistant Prostate Cancer. Clinical oncology. 34 (3), pp. e144-e145. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Elumalai, T. et al. (2022). Early Real-world Safety Data of Darolutamide in Non-metastatic Castrate-resistant Prostate Cancer. Clinical oncology. 34 (3), pp. e144-e145. [Online].